Antheia

Antheia

Their mission is to make & fairly provide Medicines to all.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
investor investor investor

€0.0

round
investor

€0.0

round
investor investor investor investor

€0.0

round
*

$56.0m

Valuation: $365m

Series C
Total Funding000k
More about Antheia
Made with AI
Edit

Antheia is a science and technology company focused on developing next-generation plant-inspired medicines. By leveraging synthetic biology, genomics, informatics, and fermentation, Antheia harnesses beneficial molecules from plants to create active pharmaceutical ingredients (APIs) in more controlled and economical ways. The company aims to disrupt the traditional agriculture-based supply chain, creating more equitable distribution channels and accelerating the discovery of new medicines. Antheia serves pharmaceutical companies and operates in the biotechnology and pharmaceutical markets. Its business model revolves around the development and sale of APIs, making money through partnerships, licensing agreements, and direct sales.

Keywords: synthetic biology, genomics, fermentation, plant-inspired medicines, active pharmaceutical ingredients, biotechnology, pharmaceutical, controlled production, economical APIs, equitable distribution.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo